'Razor blade throat': What to know about COVID-19 variant NB.1.8.1
A painful sore throat, often referred to as "razor blade throat", is just one of the symptoms of a new COVID-19 variant. This variant is currently being monitored by the World Health Organization.
"Considering the available evidence, the additional public health risk posed by NB.1.8.1 is evaluated as low at the global level," the WHO stated in a report. "Currently approved COVID-19 vaccines are expected to remain effective to this variant against symptomatic and severe disease."
In May, the WHO released a report stating it was monitoring the variant, but the variant is spreading quickly, according to the university.
The new COVID-19 variant was first detected in China in January.
NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent right now, said Subhash Verma, microbiology and immunology professor at the University of Nevada, Reno.
Verma previously said NB.1.8.1 may be able to be transferred more easily than LP.8.1. Additionally, he said that NB.1.8.1 is able to evade antibodies created by vaccines or past infections more easily than LP.8.1.
"NB.1.8.1 is likely to spread more rapidly and evade our immune defenses more easily than LP.8.1, which is why this variant requires careful monitoring," Verma said.
USA TODAY has reached out to the U.S. Centers for Disease Control and Prevention for more information on the variant.
An extremely sore throat, or "razor blade throat", is a symptom that's currently being associated with the new variant. People with the variant are saying that it feels their throats are covered with razor blades, according to Los Angeles Times, Fox News, SF Gate, and other news outlets. Many people have also taken to social media to describe the "razor blade throat".
It isn't the first time a symptom like this has been described.
With other strains, people said their throats felt like they had shards of glass jutting out, due to the extreme pain of their sore throats. This symptom, however, is gaining more popularity as the COVID-19 variant spreads.
The CDC has not outlined symptoms that are specific to the NB.1.8.1. variant. Verma said that NB.1.8.1 symptoms appear similar to those of earlier COVID-19 variants.
The CDC outlines the following as common COVID-19 symptoms:
Fever or chills
Cough
Shortness of breath or difficulty breathing
Sore throat
Congestion or a runny nose
New loss of taste or smell
Fatigue
Muscle or body aches
Headache
Nausea or vomiting
The CDC advises seeking medical care if you experience any of the following symptoms:
Trouble breathing
Persistent pain or pressure in the chest
New confusion
Inability to wake or stay awake
Depending on skin tone, lips, nail beds and skin may appear pale, gray or blue
The World Health Organization states that currently approved COVID-19 vaccines are expected to remain effective against the NB.1.8.1 variant.
In a webpage dated Jan. 7, 2025, the CDC advises that everyone over the age of six months get the 2024-2025 COVID-19 vaccine, specifically the 2024-2025 Moderna COVID-19 Vaccine.
It also suggests people who have never received a COVID-19 vaccine, are age 65 and older, are immunocompromised, live at a long-term care facility, are pregnant, breastfeeding, trying to get pregnant, and/or want to avoid getting long COVID, should get the vaccine, especially.
However, Health and Human Services Secretary Robert F. Kennedy Jr. recently recommended changes to COVID vaccinations.
On May 27, Kennedy said the COVID-19 vaccine would no longer be included in the CDC's recommended immunization schedule for healthy children and pregnant women. And on May 20, the Food and Drug Administration (FDA) said it plans to require new clinical trials for approval of the annual COVID-19 boosters for healthy individuals under the age of 65.
This could mean that some who still wish to receive the vaccine may have to pay out of pocket.
Updated and annual COVID-19 vaccines are actually not "booster shots." Boosters are additional doses of the same vaccine that are needed to maintain immunity, according to the Cleveland Clinic. Updated vaccines protect against new variants of a virus, like NB.1.8.1.
Increasing Community Access to Testing, Treatment and Response (ICATT), a federal program, continues to provide free COVID-19 testing to individuals without health insurance.
According to the CDC, as of May 27, more than 19,000 locations across the country offer free testing. To find a location near you that offers free testing, visit testinglocator.cdc.gov/Search.
Greta Cross is a national trending reporter at USA TODAY. Story idea? Email her at gcross@usatoday.com.
Julia is a trending reporter for USA TODAY. Connect with her on LinkedIn, X, Instagram and TikTok: @juliamariegz, or email her at jgomez@gannett.com
This article originally appeared on USA TODAY: What is 'razor blade throat'? What to know about new COVID-19 variant
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
41 minutes ago
- UPI
CDC vaccine expert quits after RFK Jr. cuts advisers
Dr. Fiona Havers, who led the Centers for Disease Control and Prevention's tracking of hospitalizations from COVID-19 and respiratory syncytial virus, stepped down this week. Adobe stock/HealthDay June 18 (UPI) -- A senior scientist at the U.S. Centers for Disease Control and Prevention has resigned, warning that changes in leadership may weaken the country's vaccine program. Dr. Fiona Havers, who led the CDC's tracking of hospitalizations from COVID-19 and respiratory syncytial virus, stepped down this week. "Unfortunately," she said in an email to colleagues, " I no longer have confidence that these data will be used objectively or evaluated with appropriate scientific rigor to make evidence-based vaccine policy decisions." The memo was obtained by The Washington Post. Havers' departure comes just days after U.S. Health and Human Services Secretary Robert F. Kennedy Jr. removed all members of the CDC's Advisory Committee on Immunization Practices and replaced them with new appointees. The panel makes recommendations on use of vaccines in the United States. At least three of the new members have spoken out against mRNA COVID-19 vaccines. Two have served as witnesses in lawsuits against vaccine makers, and one served on the board of the nation's oldest anti-vaccine group, The Post reported. Havers worked at the CDC for 13 years. She presented hospitalization data at advisory committee meetings. Her resignation is the latest in a string of exits from the agency. Earlier this month, Dr. Lakshmi Panagiotakopoulos, a CDC vaccine adviser, also resigned. And before that, five senior leaders stepped down from their CDC roles, The Post reported. In addition, Melinda Wharton, a top CDC official who managed advisory panel operations, was removed from her role last week. In a commentary published June 16 in JAMA, the 17 former panel members said the recent cuts have "critically weakened" the U.S. vaccine program. "We are deeply concerned that these destabilizing decisions, made without clear rationale, may roll back the achievements of U.S. immunization policy, impact people's access to lifesaving vaccines, and ultimately put U.S. families at risk of dangerous and preventable illnesses," they wrote. HHS spokesman Andrew Nixon said HHS is "committed to following the gold standard of scientific integrity" under Kennedy's leadership. "Vaccine policy decisions will be based on objective data, transparent analysis and evidence -- not conflicts of interest or industry influence," Nixon said in a statement. In her email to colleagues, Havers expressed pride in the work she and her team had done. "I'm grateful to have been part of such important and effective work that has provided decision-makers with real-time, high-quality, rigorous scientific evidence that have been used to track disease severity over time, tailor vaccine messaging to groups at highest risk for severe disease and provide critical inputs for vaccine cost-effectiveness analyses," she wrote. Just this April, Havers presented data showing that infants under 6 months old had the highest rates of COVID-related hospitalizations, The Post reported. Her report also found that most hospitalized children under 2 years old had no underlying health conditions. More information Learn more about the role of the U.S. Centers for Disease Control and Prevention. Copyright © 2025 HealthDay. All rights reserved.
Boston Globe
an hour ago
- Boston Globe
What to know about the COVID-19 variant that may cause ‘razor blade' sore throats
Experts say there isn't major cause for concern with the Nimbus variant, but here 's what else you need to know about it. Here's where the variant causing 'razor blade throat' spreading The rise in cases late last month is primarily in eastern Mediterranean, Southeast Asia and western Pacific regions, the World Health Organization said May 28. The new variant had reached nearly 11% of sequenced samples reported globally in mid-May. Advertisement Airport screening in the United States detected the new variant in travelers arriving from those regions to destinations in California, Washington state, Virginia and New York. You aren't likely to get sicker from this variant than others Not so far, anyway. The WHO said some western Pacific countries have reported increases in COVID cases and hospitalizations, but there's nothing so far to suggest that the disease associated with the new variant is more severe compared to other variants. COVID-19 vaccines are effective against the Nimbus variant Yes. The WHO has designated Nimbus as a 'variant under monitoring' and considers the public health risk low at the global level. Current vaccines are expected to remain effective. Health Secretary Robert F. Kennedy Jr. announced last month that COVID-19 shots are no longer recommended for healthy children and pregnant women — a move immediately questioned by public health experts. Advertisement AP Health Writer Carla Johnson contributed to this story.
New York Post
an hour ago
- New York Post
Anti-vax RFK could derail Trump
A word of warning to Health Secretary Robert Kennedy Jr.: Restoring Americans' trust in the feds' public health decisions means hiring truly fair-minded, science-driven folks — not anti-vax crackpots. RFK Jr. last week canned all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP), saying: 'A clean sweep is necessary to reestablish public confidence in vaccine science.' NY Post assistant editorial page editor Brooke Rogers shares this story.
